Citation Impact
Citing Papers
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
The use of mRNA display to select high-affinity protein-binding peptides
2001 StandoutNobel
Characterization of the B Cell Epitopes Associated with a Truncated Form of Pseudomonas Exotoxin (PE38) Used to Make Immunotoxins for the Treatment of Cancer Patients
2006
Magnesium-cationic Dummy Atom Molecules Enhance Representation of DNA Polymerase β in Molecular Dynamics Simulations: Improved Accuracy in Studies of Structural Features and Mutational Effects
2006 StandoutNobel
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
2001 Standout
Myasthenia Gravis
2016 Standout
Anti‐MuSK patient antibodies disrupt the mouse neuromuscular junction
2008
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
Muscle specific kinase autoimmune myasthenia gravis in children: A case series
2013
Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine
2012
Botulinum Toxin as a Biological Weapon
2001 Standout
Human milk oligosaccharides: Every baby needs a sugar mama
2012 Standout
Epidemiological and immunological profile of muscle‐specific kinase myasthenia gravis in Greece
2009
Myasthenia Gravis
1994 Standout
Carbohydrate-dependent inhibition of Helicobacter pylori colonization using porcine milk
2005
Induction of Anti-agrin Antibodies Causes Myasthenia Gravis in Mice
2018
Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis
1998
Prediction of structures of zinc‐binding proteins through explicit modeling of metal coordination geometry
2010 StandoutNobel
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences.
1997
A systematic review of population based epidemiological studies in Myasthenia Gravis
2010 Standout
Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice
2010
An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets
1993
Long‐range and short‐range mechanisms of hydrophobic attraction and hydrophilic repulsion in specific and aspecific interactions
2003
Current and emerging treatments for the management of myasthenia gravis
2011
Autoimmune Channelopathies and Related Neurological Disorders
2006
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Myasthenia gravis
2019 Standout
Evidence of hunting and hafting during the Middle Stone Age at Sibidu Cave, KwaZulu-Natal, South Africa: a multianalytical approach
2005 Standout
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
2000 Standout
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Predicting HLA CD4 Immunogenicity in Human Populations
2018
Autoantibodies to Agrin in Myasthenia Gravis Patients
2014
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Checkpoint Blockade in Cancer Immunotherapy
2006 StandoutNobel
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
2012
Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis
2012
Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis
2016
Autoimmune myasthenia gravis
2013
Successful molecular dynamics simulation of two zinc complexes bridged by a hydroxide in phosphotriesterase using the cationic dummy atom method
2001
Identifying the principal protective antigenic determinants of type A botulinum neurotoxin
1998
Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis
1998
Development of vaccines for prevention of botulism
2000
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies
2008
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Myasthenia Gravis and its Animal Model: T Cell Receptor Expression in an Antibody Mediated Autoimmune Disease
1999
An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes
2008
Nitric oxide and the immune response
2001 Standout
Protection of the Furin Cleavage Site in Low-Toxicity Immunotoxins Based on Pseudomonas Exotoxin A
2016 StandoutNobel
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Control of the Autoimmune Response by Type 2 Nitric Oxide Synthase
2001
Anti-MuSK autoantibodies block binding of collagen Q to MuSK
2011
Recombinant immunotoxin engineered for low immunogenicity and antigenicity by identifying and silencing human B-cell epitopes
2012
Anti-CTLA-4 Antibody Treatment Triggers Determinant Spreading and Enhances Murine Myasthenia Gravis
2001
Blood Residues on Fluted Points from Eastern Beringia
1998
Molecular and clinical relationship between live‐attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
2018
Agrin and LRP4 antibodies as new biomarkers of myasthenia gravis
2018
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
2011
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Antibodies against low-density lipoprotein receptor–related protein 4 induce myasthenia gravis
2013
Works of Minako Oshima being referenced
Profile of the regions of acetylcholine receptor α chain recognized by T-lymphocytes and by antibodies in eamg-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor
1994
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients
2016
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients
2015
T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients
2011
Autoimmune Recognition Profile of the Alpha Chain of Human Acetylcholine Receptor in Myasthenia Gravis
1991
Suppression of Experimental Autoimmune Myasthenia Gravis by Epitope-Specific Neonatal Tolerance to Synthetic Region α146-162 of Acetylcholine Receptor
1993
Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)
2006
Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope
2000
Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855–1296 with antitoxin antibodies from three host species
1996
Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States
2010
Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit
1990
Identification of species specific hemoglobin by isoelectric focusing
1982
B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
1996
Structure, Activity, and Immune (T and B Cell) Recognition of Botulinum Neurotoxins
1999
Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162.
1995
Different binding properties of three monoclonal antibodies to sialyl Le(x) glycolipids in a gastric cancer cell line and normal stomach tissue.
1993
T Cells of Mice Treated with mPEG-Myasthenogenic Peptide Conjugate are Involved in Protection against EAMG by Stimulating Lower Pathogenic Antibody Responses
2000
Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
1992